We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
LGI Homes
LGIH
$1.4B
| $6.03M | ﹤0.01% |
65,115
-9,622
| -13% | -$879K |
|
1777
Vital Farms
VITL
$525M
| $6.01M | ﹤0.01% |
403,139
+73,829
| +22% | +$1.02M |
|
|
SAGE
1778
DELISTED
Sage Therapeutics
SAGE
| $6.01M | ﹤0.01% |
157,541
-25,502
| -14% | -$974K |
|
1779
Nu Skin
NUS
$267M
| $6M | ﹤0.01% |
142,250
-18,932
| -12% | -$728K |
|
1780
Collegium Pharmaceutical
COLL
$956M
| $6M | ﹤0.01% |
258,409
+9,141
| +4% | +$184K |
|
|
OPI
1781
DELISTED
Office Properties Income Trust
OPI
| $5.99M | ﹤0.01% |
448,410
+110,847
| +33% | +$1.6M |
|
1782
Energizer
ENR
$1.55B
| $5.98M | ﹤0.01% |
178,269
-32,959
| -16% | -$1.01M |
|
1783
Pathward Financial
CASH
$1.8B
| $5.96M | ﹤0.01% |
138,530
-61,913
| -31% | -$2.54M |
|
|
VRAY
1784
DELISTED
ViewRay, Inc.
VRAY
| $5.95M | ﹤0.01% |
1,328,531
-162,900
| -11% | -$709K |
|
1785
Autoliv
ALV
$9B
| $5.9M | ﹤0.01% |
76,986
+42,561
| +124% | +$3.4M |
|
1786
Transmedics
TMDX
$2.91B
| $5.88M | ﹤0.01% |
95,192
-18,687
| -16% | -$993K |
|
1787
BRC Group Holdings
RILY
$289M
| $5.84M | ﹤0.01% |
170,756
+26,613
| +18% | +$1.12M |
|
1788
Geron
GERN
$949M
| $5.83M | ﹤0.01% |
936,484
-79,604
| -8% | -$178K |
|
1789
New Fortress Energy
NFE
$101M
| $5.83M | ﹤0.01% |
137,523
+818
| +0.6% | +$39.5K |
|
|
CVGW
1790
DELISTED
Calavo Growers
CVGW
| $5.82M | ﹤0.01% |
197,940
+12,963
| +7% | +$434K |
|
1791
Celldex Therapeutics
CLDX
$3.28B
| $5.81M | ﹤0.01% |
130,410
-19,236
| -13% | -$687K |
|
1792
Pilgrim's Pride
PPC
$6.54B
| $5.81M | ﹤0.01% |
244,835
-6,429
| -3% | -$153K |
|
1793
Clear Channel Outdoor Holdings
CCO
$1.23B
| $5.78M | ﹤0.01% |
5,505,194
+607,264
| +12% | +$765K |
|
1794
Pacific Biosciences
PACB
$370M
| $5.77M | ﹤0.01% |
705,107
-167,530
| -19% | -$1.44M |
|
1795
Embecta
EMBC
$262M
| $5.76M | ﹤0.01% |
227,621
+45,133
| +25% | +$1.38M |
|
1796
Immunovant
IMVT
$8.25B
| $5.75M | ﹤0.01% |
323,918
+145,490
| +82% | +$1.83M |
|
|
TPH
1797
DELISTED
Tri Pointe Homes
TPH
| $5.74M | ﹤0.01% |
308,565
-46,222
| -13% | -$804K |
|
1798
Dorman Products
DORM
$4.18B
| $5.73M | ﹤0.01% |
70,866
-4,067
| -5% | -$345K |
|
|
HBI
1799
DELISTED
Hanesbrands
HBI
| $5.73M | ﹤0.01% |
900,774
-176,098
| -16% | -$1.21M |
|
1800
SolarEdge
SEDG
$1.95B
| $5.73M | ﹤0.01% |
20,219
-260
| -1% | -$69K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.